Exelixis
EXEL
#1684
Rank
C$14.13 B
Marketcap
$49.50
Share price
1.62%
Change (1 day)
70.25%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company